Fredrik Swartling – Mechanisms behind childhood brain tumours
In our research we study how childhood brain cancers develop and whether we can find new treatments for these tumours. Using advanced modelling systems and single-cell analysis, we study genetic changes and proteins that are dysregulated in brain tumours. We are also trying to understand why some tumours relapse and how this can be treated.
MYC proteins (like MYC or MYCN) are transcription factors and PDGF proteins and their receptors are growth factors which all have essential roles in normal brain development. Misexpression of MYC proteins occurs frequently in medulloblastoma, the most common malignant childhood brain tumour of the hindbrain and PDGF and its receptors when mutated or amplified, promote the growth of malignant gliomas.
MYC or MYCN amplifications in medulloblastoma are strongly correlated with poor prognosis, suggesting that MYC proteins are clinically relevant targets for brain tumour therapy. MYC and PDGF proteins are also amplified or overexpressed in diffuse midline gliomas of in the childhood brain stem and in certain subtypes of glioblastoma, high grade malignant brain tumours typically occurring in the forebrain of adults.
Tumour origin and therapy resistance
Our research group explores how MYC proteins generate malignant brain tumours with a focus on identifying cells of tumour origin. We study critical pathways involved in relapse driven by another protein SOX9 that is important for stem cell features but also in promoting therapy resistance.
We have generated clinically relevant molecularly defined models for MYC/MYCN-driven brain tumours and we also study a large number of primary cell lines obtained from childhood brain tumour patients. Finally, we are developing forward genetic screens, clonal cell analysis, drug screening and novel computational models to understand the genomics, transcriptomics and epigenetics of these tumours at the single cell level.
Group members
Publications
Drivers Underlying Metastasis and Relapse in Medulloblastoma and Targeting Strategies
Part of Cancers, 2024
An Indolin-3-imine Photobase and pH Sensitive Fluorophore
Part of ChemPhotoChem, 2023
Part of Nature Communications, 2023
Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells
Part of Cell Death and Disease, 2023
Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas
Part of Neuro-Oncology, p. 97-107, 2023
Photoinduced ring‐opening and phototoxicity of an indolin‐3‐one derivative
Part of Chemistry - A European Journal, 2023
Part of Cell Reports, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
Part of Cancer Research, p. 4586-4603, 2022
Part of Cancers, 2022
- DOI for Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
- Download full text (pdf) of Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions
Part of RSC Advances, p. 14544-14550, 2022
Profiling chromatin accessibility in formalin-fixed paraffin-embedded samples
Part of Genome Research, p. 150-161, 2022
Part of Journal for ImmunoTherapy of Cancer, 2021
Part of Nucleic Acids Research, 2021
Part of RSC Advances, p. 23960-23967, 2021
Part of Molecular Cancer Research, p. 1831-1839, 2021
Targeting MYCN in Molecularly Defined Malignant Brain Tumors
Part of Frontiers in Oncology, 2021
Part of Cancer Research, p. 2101-2115, 2021
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
Part of Cell Reports, 2020
Medulloblastomics revisited: biological and clinical insights from thousands of patients
Part of Nature Reviews. Cancer, p. 42-56, 2020
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 20127-20138, 2020
Part of Cancers, 2020
Perturbation-based gene regulatory network inference to unravel oncogenic mechanisms
Part of Scientific Reports, 2020
Part of Bioinformatics, p. 3357-3364, 2019
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells
Part of Cell Death and Disease, 2019
Part of Cell Stem Cell, p. 433-+, 2019
Part of Cell Stem Cell, p. 855-870, 2019
Part of Journal of Pathology, p. 228-240, 2019
Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
Part of Oncogene, p. 2850-2862, 2018
GMYC: A Novel Inducible Transgenic Model of Group 3 Medulloblastoma
Part of Neuro-Oncology, p. 137-137, 2018
Part of Brain, p. 1300-1319, 2018
Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity
Part of iScience, p. 71-83, 2018
Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
Part of Nature Communications, 2018
Part of Neuro-Oncology, p. 139-139, 2018
Loss of Conservation of Graph Centralities in Reverse-engineered Transcriptional Regulatory Networks
Part of Methodology and Computing in Applied Probability, p. 1089-1105, 2017
Part of Frontiers in Oncology, 2017
Medulloblastoma: experimental models and reality
Part of Acta Neuropathologica, p. 679-689, 2017
Modeling and Targeting MYC Genes in Childhood Brain Tumors
Part of Genes, 2017
Part of Cancer Research, p. 802-812, 2017
Part of Oncotarget, p. 24815-24827, 2017
- DOI for Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
- Download full text (pdf) of Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence
Part of Molecular & Cellular Oncology, 2017
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma
Part of EMBO Journal, p. 2192-2212, 2016
Part of PLOS Genetics, 2016
- DOI for Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development-Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated Locus
- Download full text (pdf) of Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development-Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated Locus
Part of Cancer Cell, p. 72-84, 2015
Deregulated proliferation and differentiation in brain tumors
Part of Cell and Tissue Research, p. 225-254, 2015
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Part of Clinical Cancer Research, p. 912-925, 2014
Glial origin for MYCN-driven medulloblastoma and targeted prosenescence therapies
Part of Cancer Research, 2014
Part of Neuro-Oncology, p. 90-90, 2014
Metastasis and tumor recurrence from rare SOX9-positive cells in Group 4 medulloblastoma
Part of Cancer Research, 2014
Metastasis and Tumor Recurrence from Rare SOX9-Positive Cells in MYCN-Driven Medulloblastoma
Part of Neuro-Oncology, 2014
Part of Cancer Research, 2014
Oncoprotein stabilization in brain tumors
Part of Oncogene, p. 4709-4721, 2014
Signals that regulate the oncogenic fate of neural stem cells and progenitors
Part of Experimental Neurology, p. 56-68, 2014
A glial origin for medulloblastoma and inhibition of MYCN stabilization
Part of Cancer Research, 2013
Humanized Mouse Models for Medulloblastoma
Part of Neuro-Oncology, p. 30-30, 2013
Targeting the Translational Apparatus in Mycn-Driven Medulloblastoma
Part of Neuro-Oncology, p. 16-16, 2013
What underlies the diversity of brain tumors?
Part of Cancer Metastasis Review, p. 5-24, 2013
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC
Part of Cancer Cell, p. 601-613, 2012
miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma
Part of BMC Cancer, p. 378, 2012
Myc proteins in brain tumor development and maintenance
Part of Upsala Journal of Medical Sciences, p. 122-131, 2012
Pleiotropic role for MYCN in medulloblastoma
Part of Genes & Development, p. 1059-1072, 2010
Part of Oncogene, p. 3121-3131, 2009
Identifying Candidate Genes Involved in Brain Tumor Formation
Part of Upsala Journal of Medical Sciences, p. 1-38, 2008
Part of Oncogene, p. 3896-3905, 2005
Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging
Part of Proceedings of the National Academy of Sciences of the United States of America, p. 11334-11337, 2004
Dormant SOX9-positive cells behind MYC-driven medulloblastoma recurrence